Preview

Neurology, Neuropsychiatry, Psychosomatics

Advanced search

The central vein sign in the differential diagnosis of multiple sclerosis

https://doi.org/10.14412/2074-2711-2020-1S-29-32

Full Text:

Abstract

The current diagnosis of multiple sclerosis (MS) is based on confirmation of the disseminated pathological process in space and time in accordance with the McDonald criteria. Despite this, the search continues for specific markers of the disease, including those detected using neuroimaging techniques that have high sensitivity and specificity in the diagnosis of MS.

The paper considers the central vein sign, a new promising diagnostic one of MS. This sign refers to a parenchymal vein visualized in the focus of demyelination, by using special magnetic resonance imaging (MRI) modes. Studies show that the central vein sign has high sensitivity and specificity in the diagnosis of MS, allowing it to be differentiated from other demyelinating, vascular, and systemic diseases that have an MRI pattern similar to that of MS. According to various authors, a threshold of 40–50% perivenular lesions allows MS and MS-like diseases to be differentiated with high accuracy.

About the Authors

S. E. Belov
N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia
Russian Federation

Department of Neurology, Neurosurgery, and Medical Genetics

1, Ostrovityanov St, Moscow 117997



A. N. Boyko
N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia; Federal Center for the Brain and Neurotechnologies, Federal Medical Biological Agency of Russia
Russian Federation

Department of Neurology, Neurosurgery, and Medical Genetics;
Department of Neuroimmunology

1, Ostrovityanov St, Moscow 117997;
1, Ostrovityanov St, Build. 10, Moscow 117997



References

1. Thompson AJ, Banwell BL, Barkhof F, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018 Feb;17(2):162-73. doi: 10.1016/S1474-4422(17)30470-2. Epub 2017 Dec 21.

2. Rae-Grant AD, Wong C, Bernatowicz R, Fox RJ. Observations on the brain vasculature in multiple sclerosis: a historical perspective. Mult Scler Relat Disord. 2014 Mar;3(2):156-62. doi: 10.1016/j.msard.2013.08.005. Epub 2013 Dec 19.

3. Tan IL, van Schijndel RA, Pouwels PJ, et al. MR venography of multiple sclerosis. AJNR Am J Neuroradiol. Jun-Jul 2000;21(6):1039-42.

4. Tallantyre EC, Brookes MJ, Dixon JE, et al. Demonstrating the perivascular distribution of MS lesions in vivo with 7-Tesla MRI. Neurology. 2008 May 27;70(22):2076-8. doi: 10.1212/01.wnl.0000313377.49555.2e.

5. Clarke MA, Pareto D, Pessini-Ferreira L, et al. Value of 3T Susceptibility-Weighted Imaging in the Diagnosis of Multiple Sclerosis. AJNR Am J Neuroradiol. 2020 Jun;41(6):1001-8. doi: 10.3174/ajnr.A6547. Epub 2020 May 21.

6. Oh J, Sicotte NL. New imaging approaches for precision diagnosis and disease staging of MS? Mult Scler. 2020 Apr;26(5):568-75. doi: 10.1177/1352458519871817. Epub 2020 Jan 22.

7. Sinnecker T, Clarke MA, Meier D, et al; MAGNIMS Study Group. Evaluation of the central vein sign as a diagnostic imaging biomarker in multiple sclerosis. JAMA Neurol. 2019 Aug 19;76(12). doi: 10.1001/jamaneurol.2019. 2478. Online ahead of print.

8. Maggi P, Fartaria MJ, Jorge J, et al. CVSnet: A machine learning approach for automated central vein sign assessment in multiple sclerosis. NMR Biomed. 2020 May;33(5):e4283. doi: 10.1002/nbm.4283. Epub 2020 Mar 3.

9. Dworkin JD, Sati P, Solomon A, et al. Automated integration of multimodal MRI for the probabilistic detection of the central vein sign in white matter lesions. AJNR Am J Neuroradiol. 2018 Oct;39(10):1806-13. doi: 10.3174/ajnr.A5765. Epub 2018 Sep 13.

10. Sinnecker T, Kuchling J, Dusek P, et al. Ultrahigh field MRI in clinical neuroimmunology: a potential contribution to improved diagnostics and personalised disease management. EPMA J. 2015 Aug 27;6(1):16. doi: 10.1186/s13167-015-0038-y. eCollection 2015.

11. Bhandari A, Xiang H, Lechner-Scott J, Agzarian M. Central vein sign for multiple sclerosis: A systematic review and meta-analysis. Clin Radiol. 2020 Jun;75(6):479.e9-479.e15. doi: 10.1016/j.crad.2020.01.011. Epub 2020 Mar 3.

12. Tallantyre EC, Dixon JE, Donaldson I, et al. Ultra-high-field imaging distinguishes MS lesions from asymptomatic white matter lesions. Neurology. 2011 Feb 8;76(6):534-9. doi: 10.1212/WNL.0b013e31820b7630.

13. Mistry N, Dixon J, Tallantyre E, et al. Central veins in brain lesions visualized with high-field magnetic resonance imaging: a pathologically specific diagnostic biomarker for inflammatory demyelination in the brain. JAMA Neurol. 2013 May;70(5):623-8. doi: 10.1001/jamaneurol.2013.1405.

14. Maggi P, Absinta M, Grammatico M, et al. Central vein sign differentiates Multiple Sclerosis from central nervous system inflammatory vasculopathies. Ann Neurol. 2018 Feb; 83(2):283-94. doi: 10.1002/ana.25146. Epub 2018 Feb 15.

15. Maggi P, Absinta M, Sati P, et al. The «central vein sign» in patients with diagnostic «red flags» for multiple sclerosis: A prospective multicenter 3T study. Mult Scler. 2020 Apr;26(4): 421-32. doi: 10.1177/1352458519876031. Epub 2019 Sep 19.

16. Campion T, Smith RJP, Altmann DR, et al. FLAIR* to visualize veins in white matter lesions: A new tool for the diagnosis of multiple sclerosis? Eur Radiol. 2017 Oct;27(10):4257-63. doi: 10.1007/s00330-017-4822-z. Epub 2017 Apr 13.

17. Clarke MA, Samaraweera AP, Falah Y, et al. Single Test to ARrive at Multiple Sclerosis (STAR-MS) diagnosis: A prospective pilot study assessing the accuracy of the central vein sign in predicting multiple sclerosis in cases of diagnostic uncertainty. Mult Scler. 2020 Apr;26(4): 433-41. doi: 10.1177/1352458519882282. Epub 2019 Oct 31.

18. Cortese R, Magnollay L, Tur C, et al. Value of the central vein sign at 3T to differentiate MS from seropositive NMOSD. Neurology. 2018 Apr 3; 90(14):e1183-e1190. doi: 10.1212/WNL.0000000000005256. Epub 2018 Mar 7.

19. Sparacia G, Agnello F, Gambino A, et al. Multiple sclerosis: High prevalence of the 'central vein' sign in white matter lesions on susceptibility-weighted images. Neuroradiol J. 2018 Aug;31(4):356-61. doi: 10.1177/1971400918763577. Epub 2018 Mar 22.

20. Suh CH, Kim SJ, Jung SC, et al. The «Central Vein Sign» on T2*-weighted Images as a Diagnostic Tool in Multiple Sclerosis: A Systematic Review and Metaanalysis using Individual Patient Data. Sci Rep. 2019 Dec 3;9(1):18188. doi: 10.1038/s41598-019-54583-3.

21. Sati P, Oh J, Constable RT, et al. The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from he North American Imaging in Multiple Sclerosis Cooperative. Nat Rev Neurol. 2016 Dec;12(12):714-22. doi: 10.1038/nrneurol.2016.166. Epub 2016 Nov 11.


For citation:


Belov S.E., Boyko A.N. The central vein sign in the differential diagnosis of multiple sclerosis. Neurology, Neuropsychiatry, Psychosomatics. 2020;12(1S):29-32. (In Russ.) https://doi.org/10.14412/2074-2711-2020-1S-29-32

Views: 93


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2074-2711 (Print)
ISSN 2310-1342 (Online)